Assessment of Congenital Cytomegalovirus Prevalence Among Newborns in Minnesota During the COVID-19 Pandemic

Mark R Schleiss; Sondra Rosendahl; Mark McCann; Sheila C Dollard; Tatiana M Lanzieri

doi:10.1001/jamanetworkopen.2022.30020

Assessment of Congenital Cytomegalovirus Prevalence Among Newborns in Minnesota During the COVID-19 Pandemic

JAMA Netw Open. 2022 Sep 1;5(9):e2230020. doi: 10.1001/jamanetworkopen.2022.30020.

Authors

Mark R Schleiss¹, Sondra Rosendahl², Mark McCann², Sheila C Dollard³, Tatiana M Lanzieri³

Affiliations

¹ Division of Pediatric Infectious Diseases, University of Minnesota Medical School, Minneapolis.
² Newborn Screening Program, Public Health Laboratory, Minnesota Department of Health, St Paul.
³ Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia.

Abstract

This cross-sectional study assesses the prevalence of congenital cytomegalovirus infection among newborns screened in Minnesota before and during the COVID-19 pandemic.

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

COVID-19* / epidemiology
Cytomegalovirus
Cytomegalovirus Infections* / congenital
Cytomegalovirus Infections* / diagnosis
Cytomegalovirus Infections* / epidemiology
Humans
Infant, Newborn
Minnesota / epidemiology
Pandemics
Prevalence